2022 Q3 Form 10-K Financial Statement

#000147793223001577 Filed on March 20, 2023

View on sec.gov

Income Statement

Concept 2022 Q3 2022 2021 Q3
Revenue $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0%
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $2.570K $4.568K
YoY Change -98.17%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.570K $76.08K
YoY Change -69.57%
Operating Profit -$2.570K -$76.08K
YoY Change -69.57%
Interest Expense -$3.120K $12.62K
YoY Change -226.2%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$5.690K -$61.70K
YoY Change -76.27%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.690K -$61.70K
YoY Change -76.27%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 9.309M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $180.00 $180.00
YoY Change
Cash & Equivalents $177.00 $2.132K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $177.00 $180.00 $2.132K
YoY Change -91.7%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $177.00 $180.00 $2.132K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $177.00 $180.00 $2.132K
YoY Change -91.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $44.69K $44.69K $7.861K
YoY Change 468.46% 346.9%
Accrued Expenses $243.7K $244.2K $246.2K
YoY Change -1.04% -2.31%
Deferred Revenue
YoY Change
Short-Term Debt $31.53K $31.53K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $320.4K $320.4K $255.0K
YoY Change 25.67% 28.18%
LONG-TERM LIABILITIES
Long-Term Debt $92.20K $92.20K
YoY Change -7.8%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $92.20K $92.20K $96.93K
YoY Change -4.88% -7.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $320.4K $320.4K $255.0K
Total Long-Term Liabilities $92.20K $92.20K $96.93K
Total Liabilities $412.6K $412.7K $351.9K
YoY Change 17.25% 17.9%
SHAREHOLDERS EQUITY
Retained Earnings -$9.778M -$9.716M
YoY Change 0.64%
Common Stock $931.00 $108.00
YoY Change 762.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$412.5K -$412.5K -$349.8K
YoY Change
Total Liabilities & Shareholders Equity $177.00 $180.00 $2.132K
YoY Change -91.7%

Cashflow Statement

Concept 2022 Q3 2022 2021 Q3
OPERATING ACTIVITIES
Net Income -$5.690K -$61.70K
YoY Change -76.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $247.6K -$27.78K
YoY Change 38.88%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -308.9K $25.82K
YoY Change -13.93%
NET CHANGE
Cash From Operating Activities 247.6K -$27.78K
Cash From Investing Activities
Cash From Financing Activities -308.9K $25.82K
Net Change In Cash -61.24K -$1.955K
YoY Change -119.55%
FREE CASH FLOW
Cash From Operating Activities $247.6K -$27.78K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001386044
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 fhld Note Payable Related Party
NotePayableRelatedParty
0 usd
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-54853
CY2022 dei Entity Registrant Name
EntityRegistrantName
Freedom Holdings, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2560951
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
6461 N 100 E
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Ossian
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
IN
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
46777
CY2022 dei City Area Code
CityAreaCode
260
CY2022 dei Local Phone Number
LocalPhoneNumber
490-9990
CY2022 dei Security12g Title
Security12gTitle
Common Stock, $0.0001 par value
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Public Float
EntityPublicFloat
2423063 usd
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9308825 shares
CY2022 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2022 dei Auditor Firm
AuditorFirmId
5041
CY2022 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q3 fhld Note Payable Related Party
NotePayableRelatedParty
31530 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9308825 shares
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9716132 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-349792 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2132 usd
CY2022 fhld Consulting Services Related Party
ConsultingServicesRelatedParty
0 usd
CY2021 fhld Consulting Services Related Party
ConsultingServicesRelatedParty
31400 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31400 usd
CY2022 us-gaap Gross Profit
GrossProfit
0 usd
CY2021 us-gaap Gross Profit
GrossProfit
0 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
0 usd
CY2021 us-gaap Management Fee Expense
ManagementFeeExpense
240000 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
71510 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
2934 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4568 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2243 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
76078 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
245177 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-76078 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-245177 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
27000 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022 us-gaap Interest Expense
InterestExpense
12620 usd
CY2021 us-gaap Interest Expense
InterestExpense
14301 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.00
CY2021 fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.24
CY2022 fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
160376744 shares
CY2021 fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
1077582 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-121714 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
31400 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-259478 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-349792 usd
CY2022 fhld Cancellation Of Common Shares Amount
CancellationOfCommonSharesAmount
-980 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-61698 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-412470 usd
CY2022 us-gaap Profit Loss
ProfitLoss
61698 usd
CY2021 us-gaap Profit Loss
ProfitLoss
259478 usd
CY2022 fhld Increase Decrease In Accounts Payable And Accruals
IncreaseDecreaseInAccountsPayableAndAccruals
34273 usd
CY2021 fhld Increase Decrease In Accounts Payable And Accruals
IncreaseDecreaseInAccountsPayableAndAccruals
233890 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-350 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
922 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27775 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24666 usd
CY2022 fhld Proceeds From Paidin Capital Related Party
ProceedsFromPaidinCapitalRelatedParty
0 usd
CY2021 fhld Proceeds From Paidin Capital Related Party
ProceedsFromPaidinCapitalRelatedParty
31400 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4730 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4621 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
31530 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022 fhld Payments Of Cancellation Of Common Stock
PaymentsOfCancellationOfCommonStock
980 usd
CY2021 fhld Payments Of Cancellation Of Common Stock
PaymentsOfCancellationOfCommonStock
0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25820 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26779 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1955 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2113 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2132 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
177 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2132 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
12620 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
14301 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p>
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2132 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
170000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9777830 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-61698 usd
CY2017Q3 us-gaap Unsecured Debt
UnsecuredDebt
50000 usd
CY2017Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
CY2022 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
750.00 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
92203 usd
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
96933 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
573 usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
922 usd
CY2022Q3 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
92776 usd
CY2021Q3 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
97855 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
243654 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
246208 usd
CY2021Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
710676 shares
CY2021Q4 fhld Series Abc And D Preferred Stock Shares Converted Into Number Of Common Stocks Shares
SeriesABCAndDPreferredStockSharesConvertedIntoNumberOfCommonStocksShares
15920945 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
710496 shares
CY2021Q4 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
1 pure
CY2021Q4 fhld Share Exchange For Common Stock Shares
ShareExchangeForCommonStockShares
311672730 shares
CY2021Q4 fhld Share Exchange For Common Stock Per Share Amount
ShareExchangeForCommonStockPerShareAmount
1.00
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9308825 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1079116 shares
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
13000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
54000 usd
CY2022 fhld Federal Income Taxes Valuation Allowance
FederalIncomeTaxesValuationAllowance
-13000 usd
CY2021 fhld Federal Income Taxes Valuation Allowance
FederalIncomeTaxesValuationAllowance
-54000 usd
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2021 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
170000 usd
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
157000 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
170000 usd
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
157000 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
170000 usd
CY2022 fhld Deferred Tax Percentage Rate
DeferredTaxPercentageRate
0.21 pure

Files In Submission

Name View Source Status
0001477932-23-001577-index-headers.html Edgar Link pending
0001477932-23-001577-index.html Edgar Link pending
0001477932-23-001577.txt Edgar Link pending
0001477932-23-001577-xbrl.zip Edgar Link pending
fhld-20220930.xsd Edgar Link pending
fhld_10k.htm Edgar Link pending
fhld_ex311.htm Edgar Link pending
fhld_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
fhld-20220930_lab.xml Edgar Link unprocessable
fhld-20220930_pre.xml Edgar Link unprocessable
fhld-20220930_def.xml Edgar Link unprocessable
fhld_10k_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fhld-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable